SCHEMBL13613640

SCHEMBL13613640

COc1ccc(CNC(=O)Nc2cccc3c2CC(O)CC3)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 12/20 0.49
OPRM1 P35372 1/20 0.49
MGAM O43451 1/20 0.47
GAA P10253 1/20 0.47
SI P14410 1/20 0.47
MGAM2 Q2M2H8 1/20 0.47
KMT2A Q03164 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 1/20 0.45
NAMPT P43490 1/20 0.44
ROCK2 O75116 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4339142 0.89 TRPV1 (0.48) TRPV1OPRM1KMT2ACYP1A2CYP3A4
SCHEMBL13613632 0.88 LMNA (0.54) TRPV1OPRM1GAAKMT2AALDH1A1
SCHEMBL13613633 0.85 ALDH1A1 (0.50) TRPV1OPRM1GAAKMT2AALDH1A1
SCHEMBL13613614 0.85 KDM4E (0.56) TRPV1OPRM1KMT2AALDH1A1
SCHEMBL2734372 0.84 F3 (0.45) TRPV1OPRM1GAAKMT2ACYP1A2
SCHEMBL2734530 0.84 L3MBTL1 (0.48) TRPV1OPRM1KMT2ACYP1A2CYP3A4
SCHEMBL13613647 0.83 GAA (0.56) TRPV1OPRM1GAAKMT2ACYP1A2
SCHEMBL2734754 0.83 KDM4E (0.53) TRPV1OPRM1KMT2AALDH1A1ROCK2
SCHEMBL2733717 0.82 TRPV1 (0.50) TRPV1OPRM1KMT2AALDH1A1ROCK2
SCHEMBL2734544 0.80 TRPV1 (0.48) TRPV1OPRM1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed